New inhibitor brings new hope

Scientists from the cluster of excellence BIOSS Centre for Biological Signalling Studies at the University of Freiburg and the Freiburg University Medical Center have shown that inhibiting the epigenetic regulator KDM4 might offer a potential novel treatment option for breast cancer patients. They used a newly established cell model that enables scientists to isolate cancer stem cells directly from patient tumor. Using this special culture system, they were able to test potential new cancer drugs. One of these, a novel inhibitor of the epigenetic regulator KDM4, co-developed in the lab of Prof. Schüle, showed promising results. The researchers now published their work in the scientific journal Cancer Research.

New inhibitor brings new hope

Scientists from the cluster of excellence BIOSS Centre for Biological Signalling Studies at the University of Freiburg and the Freiburg University Medical Center have shown that inhibiting the ...

Thu 14 Sep 17 from Medical Xpress

New inhibitor brings new hope, Thu 14 Sep 17 from Eurekalert

  • Pages: 1

Bookmark

Bookmark and Share